SANDRA SPERLING: Open Payments
NPI 1629013545 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 57 payments from 14 companies in 2025. Trend: 2023 $2,227 · 2024 $1,802 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $402 |
| Axsome Therapeutics, Inc. | 7 | $283 |
| Vanda Pharmaceuticals Inc. | 6 | $171 |
| Corium, LLC | 3 | $127 |
| Neurocrine BioSciences, Inc. | 5 | $105 |
| Lundbeck LLC | 2 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Tris Pharma Inc | 3 | $59 |
| Almatica Pharma LLC | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
Products named: VRAYLAR, Auvelity, FANAPT, REXULTI, Azstarys, INGREZZA, Dyanavel XR, LOREEV XR.
Industry payments across IN — which companies pay providers there.
